Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.17EBITDA per Share
VS
Market
Sector
Industry
History
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -1.13M | $ -0.17 | 1 | 6.8M |
| 3/31/2025 | $ 30.66M | $ 4.18 | 1 | 7.33M |
| 12/31/2024 | $ 20.25M | $ 2.91 | 1 | 6.96M |
| 9/30/2024 | $ 22.68M | $ 2.97 | 1 | 7.64M |
| 6/30/2024 | $ 26.94M | $ 3.42 | 1 | 7.87M |
| 3/31/2024 | $ 333.76K | $ 0.03 | 1 | 9.58M |
| 12/31/2023 | $ -1.14M | $ -0.13 | 1 | 8.61M |
| 9/30/2023 | $ -1.28M | $ -0.15 | 1 | 8.77M |
| 6/30/2023 | $ -5.95M | $ -0.47 | 1 | 12.6M |
| 3/31/2023 | $ -4.32M | $ -0.22 | 1 | 19.49M |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -2.25.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average EBITDAPS has been $ 0.09.
- The median EBITDAPS for PHARMACYTE BIOTECH INC during this period was $ -0.22
- PHARMACYTE BIOTECH INC reached its highest EBITDAPS over the past 5 years at $ 4.18.
- The lowest EBITDAPS recorded by PHARMACYTE BIOTECH INC in the same timeframe $ -2.45
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for PHARMACYTE BIOTECH INC is calculated as follows: EBITDA [ $ -3.46M ] / (Shares WA [ 1.54M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -2.25 ] PMCB - EBITDA per Share, Last 5 years
$ -2.45
Minimum
Mar 31, 2021
$ 4.18
Maximum
Mar 31, 2025
$ 0.09
Average
$ -0.22
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |